About
Professional Summary
Dr. Arvind Kumar Shukla is working on the Molecular mechanism of Cancer Stem Cells Biology. He is the main focus in the fabrication of functional tissue/organs development by 3D Bioprinting with a study on Stem cells & Cancer signaling pathways and also focuses on various cancer drugs delivery, which are used tested clinically for treatment of Chronic Myeloid Leukemia (CML), Acute myeloid leukemia (AML), Colorectal Cancer (CRC), Breast Cancer and other type of Solid Cancer. He is focus basic medical and scientific research on cancer biology two areas: 1) the mechanisms by which cancers invade and metastasize and 2) the mechanisms by which cancer cells evade immune responses. Cancer arises in a multi-step process in which normal cells acquire mutations through the activation of oncogenes and the loss of tumor suppressor mechanisms. He is interested in examining the signaling pathways in cancer cells in order to understand the molecular events leading to tumor growth, invasion, metastasis, immune suppression and multidrug resistance.
Employment
Professional Appointments
Sr. Researcher
Pusan National University, School of Biomedical Convergence Engineering, Yangsan 50612, South Korea.
Feb 2020 — Aug 2025
|
Yangsan, South Korea
Visit organization profile
Education
Academic Background
-
M.B.A
Pad. Dr. D. Y. Patil Medical College, Pune , India
Healthcare Management | Jun 2022 — Jun 2024
-
Ph.D.
Pusan National University, Korea
Biomedical Conversion Engineering | Feb 2020 — Aug 2025
-
M.Sc.
Dr. D. Y. Patil University, India
Genetic Engineering and Gene Therapy | Jun 2012 — Jun 2014
-
B.Sc.
Mumbai University, India
Zoology and Environmental Biology | Jun 2008 — Jun 2012
Publications (13)
Selected Scholarly Contributions
Polymer-Enabled Additive Manufacturing for Personalized Drug Delivery and Diagnostic Platforms: Materials, Architectures, Quality Control and Clinical Translation
Parthiban Pandian, Veeran Sethuraman, Arvind Kumar Shukla, Arulkumar Nagappan
Polymers
| Journal Article
2026
Farnesol as a Multifunctional Regulator of Fungal Biology: Mechanisms and Significance
Shaurya Prakash, Neeraj Kumar Rai, Sandhya Shukla, Radha Arulkumar, Arvind Kumar Shukla, Arulkumar Nagappan
Applied Microbiology
| Journal Article
2026
Advancing Neurovascular Model Engineering with Integrated 3D Bioprinting and Microfluidic Chips for Study of Neurovascular and Neurodegenerative Disease Pathophysiology
Arvind Kumar Shukla, Won-Woo Cho, Minjun Ahn, Sandhya Shukla, Adarsha Mahendra Upadhyay, Arulkumar Nagappan, Raj Kumar Mongre, Byoung Soo Kim
Bioprinting
| Journal Article
2026
Oncogenic EGFR Signaling as a Central Regulator of Chemoresistance in Ovarian Cancer: A Mechanistic Review
Arulkumar Nagappan, Veeran Sethuraman, Parthiban Pandian, Jothi Nedunchezhian, Arvind Kumar Shukla
International Journal of Molecular Sciences
| Journal Article
2026
Exploring the angiogenic potential of skin patches with endothelial cell patterns fabricated via in-bath 3D bioprinting using light-activated bioink for enhanced wound healing
Arvind Kumar Shukla, Minjun Ahn, Jun Gao, Dongjun Lee, Sik Yoon, Sae-Ock Oh, Ge Gao, Won-Woo Cho, Byoung Soo Kim
Biomaterials
| Journal Article
2026
Targeting Pathways and Mechanisms in Gynecological Cancer with Antioxidant and Anti-Inflammatory Phytochemical Drugs
Sandhya Shukla, Arvind Shukla, Navin Ray, Adarsha Upadhyay, Fowzul Fahad, Sayan Dutta, Arulkumar Nagappan, Raj Mongre
Onco
| Journal Article
2025
Molecular Insight and Antioxidative Therapeutic Potentials of Plant-Derived Compounds in Breast Cancer Treatment
Sandhya Shukla, Arvind Shukla, Adarsha Upadhyay, Navin Ray, Fowzul Fahad, Arulkumar Nagappan, Sayan Dutta, Raj Mongre
Onco
| Journal Article
2025
Integrating 3D Bioprinting with Organoid Technology-Based Breast Cancer Models for Drug Evaluation
Arvind Kumar Shukla, Sandhya Shukla, Raj Kumar Mongre, Adarsha Mahendra Upadhyay, Govindhan Thiruppathi, Chandra Dhar Shukla, Shuktika Mishra, Sayan Deb Dutta
Organoids
| Journal Article
2025
High-Throughput 3D Bioprinted Organoids of Skin Cancer Utilized for Diagnosis and Personalized Therapy
Arvind Kumar Shukla, Sandhya Shukla, Sonali Pradeep Suryawanshi, Adarsha Mahendra Upadhyay, Navin Ray, Govindhan Thiruppathi, Sayan Deb Dutta, Raj Kumar Mongre
Current Oncology
| Journal Article
2025
Advancement in Cancer Vasculogenesis Modeling through 3D Bioprinting Technology
Arvind Kumar Shukla, Sik Yoon, Sae-Ock Oh, Dongjun Lee, Minjun Ahn, Byoung Soo Kim
Biomimetics
| Journal Article
2024
Applications of 3D Bioprinting Technology in Induced Pluripotent Stem Cells-Based Tissue Engineering
Arvind Kumar Shukla, Ge Gao, Byoung Soo Kim
Micromachines
| Journal Article
2022
Recent Advancements in Nanoparticle-Based Optical Biosensors for Circulating Cancer Biomarkers
Chaima Amri, Arvind Kumar Shukla, Jin-Ho Lee
Materials
| Journal Article
2021
Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure?
Raj Kumar Mongre, Chandra Bhushan Mishra, Arvind Kumar Shukla, Amresh Prakash, Samil Jung, Md Ashraf-Uz-Zaman, Myeong-Sok Lee
International Journal of Molecular Sciences
| Journal Article
2021
